Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis

Dermatology

Volumn 222, Issue 4, 2011, Pages 358-362

  Gholam, Patrick ^a   Weberschock, Tanja ^a   Denk, Katharina ^a   Enk, Alexander ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

5 Aminolaevulinic acid methylester; 5 Aminolaevulinic acid nanoemulsion; Actinic keratosis; Methylaminolaevulinate; Metvix; Pain; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; IBUPROFEN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NANOEMULSION; PAIN; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; EMULSIONS; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; NANOMEDICINE; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80052501909     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000329025     Document Type: Article

References (20)

1. Morton CA, McKenna KE, Rhodes LE: Guidelines for topical photodynamic therapy: Update. Br J Dermatol 2008; 159: 1245-1266.
2. Gholam P, Denk K, Sehr T, Enk A, Hartmann M: Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010; 63: 213-218.
3. Miller I, Nielsen J, Lophaven S, Jemec G: Factors related to pain during routine photodynamic therapy: A descriptive study of 301 patients. J Eur Acad Dermatol Venereol 2011, E-pub head of print.
4. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM: Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497. (Pubitemid 35278943)
5. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M, Gudmundson F, Ericson MB, Larko O, Wennberg AM: Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006; 86: 404-408. (Pubitemid 44450094)
6. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC: Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727-733. (Pubitemid 351415749)
7. Babilas P, Knobler R, Hummel S, Gottschaller C, Maisch T, Koller M, Landthaler M, Szeimies RM: Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: A prospective randomized controlled trial. Br J Dermatol 2007; 157: 111-117. (Pubitemid 46934274)
8. Babilas P, Kohl E, Maisch T, Backer H, Gross B, Branzan AL, Baumler W, Landthaler M, Karrer S, Szeimies RM: In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 2006; 154: 712-718. (Pubitemid 43374097)
9. Babilas P, Travnik R, Werner A, Landthaler M, Szeimies RM: Split-face-study using two different light sources for topical PDT of actinic keratoses: Non-inferiority of the LED system. J Dtsch Dermatol Ges 2008; 6: 25-32.
10. Kasche A, Luderschmidt S, Ring J, Hein R: Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006; 5: 353-356.
11. Wiegell SR, Stender IM, Na R, Wulf HC: Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003; 139: 1173-1177. (Pubitemid 37128379)
12. Maisch T, Santarelli F, Schreml S, Babilas P, Szeimies RM: Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol 2010; 19:e302-e305.
13. Jemec GB: A simple method for routine measure of photodynamic therapy-associated pain. Photodermatol Photoimmunol Photomed 2010; 26: 51-52.
14. Moloney FJ, Collins P: Randomized, doubleblind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007; 157: 87-91. (Pubitemid 46934264)
15. Rud E, Gederaas O, Hogset A, Berg K: 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000; 71: 640-647.
16. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE: Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 2001; 62: 140-145. (Pubitemid 32898834)
17. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM, Giercksky KE: Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 1995; 62: 906-913. (Pubitemid 3001597)
18. Ahmadi S, McCarron PA, Donnelly RF, Woolfson AD, McKenna K: Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: A pilot study. Exp Dermatol 2004; 13: 445-451. (Pubitemid 39077312)
19. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H: Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 1998; 68: 218-221. (Pubitemid 128472013)
20. Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krahn-Senftleben G, Reich K, Pabst G, Voss D, Foguet M, Gahlmann R, Lubbert H, Reinhold U: Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: Results of a prospective, randomized, double-blind, placebo- controlled phase III study. Br J Dermatol 1010; 163: 386-394.